Central opiate modulation of growth hormone and insulin-like growth factor-I

Brain Research Bulletin

Volumn 40, Issue 2, 1996, Pages 99-104

  Hashiguchi, Yojiro ^a   Molina, Patricia E ^a   Fan, Jie ^a   Lang, Charles H ^a   Abumrad, Naji N ^a  

^a STONY BROOK UNIVERSITY   (United States)

Author keywords

ICV; IGFBP 1; Morphine sulfate; Morphine 6 glucuronide; Rats

Indexed keywords

ADRENALIN; CORTICOSTERONE; GLUCOSE; GROWTH HORMONE; INSULIN; MORPHINE 6 GLUCURONIDE; MORPHINE SULFATE; NORADRENALIN; RECEPTOR SUBTYPE; SOMATOMEDIN; SOMATOMEDIN BINDING PROTEIN 1;

ANIMAL CELL; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DRUG MECHANISM; HORMONAL REGULATION; HORMONE RECEPTOR INTERACTION; IMMUNOMODULATION; INTRACEREBROVENTRICULAR DRUG ADMINISTRATION; MALE; NONHUMAN; OPIATE ADDICTION; PRIORITY JOURNAL; RAT; RECEPTOR AFFINITY; REGULATORY MECHANISM;

EID: 0029996870     PISSN: 03619230     EISSN: None     Source Type: Journal    
DOI: 10.1016/0361-9230(96)00045-7     Document Type: Article

References (20)

1. Baxter, R. C.; Martin, J. L. Binding proteins for the insulin-like growth factors: Structure, regulation and function. Prog. Growth Factor Res. 1:49-68; 1989.
2. Cappon, J.; Brasel, A.; Mohan, S.; Cooper, D. M., Effect of brief exercise on circulating insulin-like growth factor I. J. Appl. Physiol. 76:2490-2496; 1994.
3. Collu, R.; Clermont, M. M.; Ducharme, J. R. Effects of thyrotropin-releasing hormone on prolactin, growth hormone and corticosterone secretions in adult male rats treated with pentobarbital or morphine. Eur. J. Pharmacol. 37:133-140; 1976.
4. Fan, J.; Char, D.; Kolasa, A. J.; Pan, W.; Maitra, S. R.; Patlak, C. S.; Spolarics, Z.; Gelato, M. C.; Lang, C. H. Alterations in hepatic production and peripheral clearance of IGF-1 after endotoxin. Am. J. Physiol. 269:E33-E42; 1995.
5. Gelato, M. C.; Vassalotti, J.; Spatola, E.; Rutherford, C.; Marsh, K.; Carlson, H. E. Differential tissue regulation of the insulin-like growth factors in rats bearing the MStT/W15 pituitary tumor. Neuroendocrinology 56:765-774; 1991.
6. Gong, Q. L.; Hedner, T.; Hedner, J.; Björkman, R.; Nordberg, G. Antinociceptive and ventilatory effects of the morphine metabolites: Morphine-6-glucuronide and morphine-3-glucuronide. Eur. J. Pharmacol. 193:47-56; 1991.
7. Hashiguchi, Y.; Molina P. E.; Abumrad, N. N. Morphine-3-glucuronide: Hyperglycemic and neuroendocrine potentiating effects. Brain Res., in press.
8. Hashiguchi Y.; Molina, P. E.; Preedy, V. R.; Sugden, P. H., McNurlan, M. A.; Garlick, P. J.; Abumrad, N. N. Central effects of morphine and morphine-6-glucuronide on tissue protein synthesis. (Submitted for publication).
9. Hooper, S. B.; Bocking, A. D.; White, S. E.; Fraher, L. J.; McDonald, T. J.; Han, V. K. M. Catecholamines stimulate the synthesis and release of insulin-like frowth factor binding protein-1 (IGFBP-1) by fetal sheep liver in vivo. Endocrinology 134:1104-1112; 1994.
10. Koenig, J. I.; Mayfield, S. M.; McCann, S. M.; Krulich, L. Differential role of the opioid μ and δ receptors in the activation of prolactin (PRL) and growth hormone (GH) secretion by morphine in the male rat. Life Sci. 34:1829-1837; 1984.
11. Kokka, N.; Gacia, J. F.; Elliot, H. W. Effects of acute and chronic administration of narcotic analgesics in rat. Proc. R. Soc. Lond. 225:27-40; 1973.
12. Krulich, L.; Koenig, J. I.; Conway, S.; McCann, S. M.; Mayfield, M. A. Opioid receptors and the secretion of prolactin (PRL) and growth hormone (GH) in the rat. Neuroendocrinology 42:75-81; 1986.
13. Laatikainen, T.; Anttila, L.; Suikkari, A. M.; Ruutiainen, K.; Erkkola, R.; Seppälä, M. Effect of naloxone on plasma insulin, insulin-like growth factor I, and its binding protein 1 in patients with polycystic ovarian disease. Fertil. Steril. 54:434-437; 1990.
14. Luo, J.; Reid, R. E.; Murphy, L. J. Dexamethasone increases hepatic insulin-like growth factor binding protein-1 (IGFBP-1) mRNA and serum IGFBP-1 concentrations in the rat. Endocrinology 127:1456-1462; 1990.
15. McCusker, R. H.; Clemmons, D. R. The insulin-like growth factor binding proteins: structure and biological functions. In: Scofield, P. N., ed. The insulin-like growth factors, structure and biological function. New York: Oxford Medical Publications; 1992: 110-150.
16. Mignat, C.; Wille, U.; Ziegler, A. Affinity profiles of morphine, codeine, dihydrocodeine and their glucuronides at opioid receptor subtypes. Life Sci. 56:793-799; 1995.
17. Molina, P. E.; Hashiguchi, Y.; Ajmal, M.; Mazza, M.; Abumrad, N. N. Differential hemodynamic, metabolic and hormonal effects of morphine and morphine-6-glucuronide. Brain Res. 664:126-132; 1994.
18. Paul, D.; Standifer, K. M.; Inturrisi, C.E.; Pasternak, W. Pharmacological characterization of morphine-6β-glucuronide, a very potent morphine metabolite. J. Pharmacol. Exp. Ther. 251:477-483; 1989.
19. Pechnich, R.; George, R.; Poland, R. E. Identification of multiple opiate receptors through neuroendocrine responses. II. Antagonism of mu, kappa and sigma agonists by naloxone and Win 44,441-3. J. Pharmacol. Exp. Ther. 232:170-177; 1985.
20. Unterman T. G.; Oehler, D. T.; Murphy, L. J.; Lacson, R.G. Multihormonal regulation of insulin-like growth factor-binding protein 1 in rat H4-IIE hepatoma cells: The dominant role of insulin. Endocrinology 128:2693-2701; 1991.